Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.850
-0.110 (-5.61%)
At close: Sep 16, 2025, 4:00 PM EDT
1.870
+0.020 (1.08%)
After-hours: Sep 16, 2025, 5:57 PM EDT
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $13.14 million as of September 16, 2025. Its market cap has decreased by -21.49% in one year.
Market Cap
13.14M
Enterprise Value
16.48M
1-Year Change
-21.49%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $13.14M, a decrease of -96.84%. That is a compound annual growth rate of -40.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 14.00M | -10.84% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | 84.01M | -81.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |